Bolt Biotherapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Bolt Biotherapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bolt Biotherapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bolt Biotherapeutics Inc. is BOLT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bolt Biotherapeutics Inc. has its primary listing on NASDAQ. You can trade Bolt Biotherapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bolt Biotherapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bolt Biotherapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bolt Biotherapeutics Inc..